LMS News

2007-04-03
LMS Announces Second Generation of CALM SHOULDER SCREEN™

LMS Newsletter - Montreal, Quebec, April X, 2007 - LMS Medical Systems, a healthcare technology company and developer of the CALMTM clinical information system and risk management software tools for obstetrics, today announced that it has just released the second generation of its CALM Shoulder Screen risk management tool. The enhanced performance of this advanced version has been derived from data equivalent to the occurrence of shoulder dystocia with permanent injury in over 1.8 million deliveries.

Until recently, all attempts to develop a probabilistic model have been stymied by the challenge of collecting sufficient data on this relatively uncommon but devastating condition. After several years of clinical research, in 2006 LMS launched the first version of CALM Shoulder Screen to assess the risk of shoulder dystocia associated with immediate neonatal injury. The patent pending algorithm has now been refined to specifically assess the risk of one of the severest forms of these injuries, permanent brachial plexus injury, which is one of the top two most costly obstetrical litigation issues. This second generation tool can also be applied over a wider range of maternal and fetal sizes.

Shoulder dystocia occurs when the baby's shoulder gets stuck behind the mother's pubic bone during the delivery and can lead to potentially severe complications such as brachial plexus impairment, fractured clavicle, and brain damage. Until recently considered largely unpredictable and unpreventable, shoulder dystocia is responsible for some 30,000 delivery complications every year in North America.

About LMS:LMS is a leader in the application of advanced mathematical modeling and neural networks for medical use. The LMS CALM Decision Support Suite™ provides physicians, nursing staff, risk managers and hospital administrators with clinical information systems and risk management tools designed to improve outcomes and patient care for mothers and their infants during childbirth.

For further information please contact:

Andrea Miller, Communications
LMS Medical Systems Inc.
Tel: (514) 488-3461 Ext. 222
Fax: (514) 488-1880
E-mail: investor@lmsmedical.com
Website: www.lmsmedical.com

Except for historical information contained herein, the matters discussed in this news release are forward-looking statements. Because these forwardlooking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed implied by the forward-looking statements including, but without limitation, economic conditions in general and in the healthcare market, the demand for and market for our products in domestic and international markets, our current dependence on the CALM product suite, the challenges associated with developing new products and obtaining regulatory approvals if necessary, research and development activities, the uncertainty of acceptance of our products by the medical community, the lengthy sales cycle for our products, third party reimbursement, competition in our markets, including the potential introduction of competitive products by others, our dependence on our distributors, physician training, enforceability and the costs of enforcement of our patents, potential infringements of our patents and the other factors set forth from time to time in the Company's filings with the United States Securities and Exchange Commission and with the Canadian Securities Commissions. The Company has no intention of or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.